A growing body of evidence indicates that SDC1 is released into the circulation in response to endothelial injury [14,15] and elevated levels of serum SDC1 have been detected in patients with severe sepsis [16] and have been associated with adverse clinical outcomes in patients with ischemic heart failure [17]. This evidence concerns the gene SDC1 and Sepsis.